Article info
PDFClinical ethics
Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists
- Correspondence to Ms Yrrah Stol, University of Amsterdam/Centre for Society and Genomics, Nijmegen, Amsterdam, The Netherlands; yrrah_stol{at}yahoo.com
Citation
Informing family members about a hereditary predisposition to cancer: attitudes and practices among clinical geneticists
Publication history
- Received September 14, 2009
- Revised March 9, 2010
- Accepted March 12, 2010
- First published July 6, 2010.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Other content recommended for you
- Healthcare professionals’ responsibility for informing relatives at risk of hereditary disease
- Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry
- Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
- Cultural aspects of cancer genetics: setting a research agenda
- Genetic counselling in ALS: facts, uncertainties and clinical suggestions
- Opportunistic genetic screening increases the diagnostic yield and is medically valuable for care of patients and their relatives with hereditary cancer
- Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals
- Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations